KALV: KalVista Pharmaceuticals Inc Sotuvga nisbatan narx
KalVista Pharmaceuticals noyob immun patologiyalarini davolash uchun innovatsion tabletkalarni ishlab chiqmoqda va inyeksiyalarni og'iz orqali qabul qilinadigan dori vositalari bilan almashtirmoqda. Kompaniyaning P/S koeffitsiyentini kuzatish emitentning bozor qiymatini daromadga nisbatan baholashga yordam beradi, bunda 966.80 qiymati metrika darajasini ifodalaydi. Biroq, biznes yagona mahsulotga tayanadi, bu esa nisheyga bog'liqlikni yuzaga keltiradi. Istiqbollar klinik sinovlar xavflari va qo'shimcha kapitalga bo'lgan ehtiyoj bilan cheklangan.
KalVista Pharmaceuticals (KALV) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati KalVista Pharmaceuticals|KALV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati KalVista Pharmaceuticals|KALV - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar KalVista Pharmaceuticals|KALV - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi KalVista Pharmaceuticals|Oraliq likvidlik koeffitsiyenti kalvista.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
KALV - Sof foyda|Prognoz qilingan kelajakdagi foyda KalVista Pharmaceuticals|KALV - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori KalVista Corp|KALV - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati KalVista Corp|KALV - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun foyda KalVista Pharmaceuticals|KALV - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi kalvista.com|KALV - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi KalVista Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:KALV, KalVista Pharma
P/S koeffitsienti bozor kapitalizatsiyasini yillik daromad bilan solishtiradi, bu esa sotuvlarning har bir birligi qiymatini baholash va haddan tashqari sotib olingan aktivni aniqlash imkonini beradi. Daromad koeffitsiyenti darajasini tahlil qilish orqali investor klinik sinovlarning ulkan xarajatlarini va noyob kasalliklar sektoridagi innovatsion ishlanmalarining yuqori darajadagi himoyasini hisobga olgan holda, KalVista Pharmaceuticals (KALV) ga nisbatan bozor kutuvlarining qanchalik shishirilganligini baholashi mumkin.
KalVista Pharmaceuticals raqobatchilari
argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols Biemat) - P/S multiplikatori|P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning daromadga nisbati Celldex Therapeutics (CLDX)|Narx/daromad koeffitsiyenti auriniapharma.com|Narxning daromadga nisbati BioCryst Pharmaceuticals BCRX|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Pharma - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL: P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati Intrexon|PHAR - Narx/daromad multiplikatori|P/S multiplikatori NKTR|Narxning daromadga nisbati UPB (Upstream Bio Corp)|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Narx/daromad koeffitsiyenti immunome.com (IMNM)|Gossamer Bio Inc - P/S multiplikatori|SEPN (Septerna) - Kapitalizatsiya va daromad nisbati|Pieris Corp (PVLA) - Narxning daromadga nisbati|SVRA - Narx/daromad koeffitsiyenti|RIGL (rigel.com) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANAB (AnaptysBio, Inc.)|P/S multiplikatori ATXS|enGene Holdings Inc (ENGN) - Narx/daromad multiplikatori|P/S multiplikatori RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Narxning sotuvga nisbati|ACRS: Kapitalizatsiyaning daromadga nisbati|KYTX - P/S multiplikatori|TLSA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Cabaletta Bio, Inc|Narxning daromadga nisbati Ventyx Biosciences, Inc|THTX: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati AVTX (Avalo Therapeutics, Inc)|Kapitalizatsiyaning daromadga nisbati Eledon Pharmaceuticals ELDN|Narxning daromadga nisbati Agenus, Inc. AGEN|P/S multiplikatori Climb Bio Inc. CLYM|ZURA - Narxning daromadga nisbati|Narxning sotuvga nisbati ATYR|ADAG (Adagene Inc.) - Kapitalizatsiyaning daromadga nisbati|ImageneBio Inc (IMA) - P/S multiplikatori|Narxning daromadga nisbati Shattuck Therapeutics|Kapitalizatsiyaning daromadga nisbati equilliumbio.com (EQ)|P/S multiplikatori CNTB|Narx/daromad koeffitsiyenti Immunic Therapeutics|P/S multiplikatori ATRA (Atara Biotherapeutics, Inc.)|IFRX - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Kapitalizatsiya va daromad nisbati|CELU: P/S multiplikatori|INMB - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Barinthus Biotherapeutics plc|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|AKTX (Akari Therapeutics Plc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Narxning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|edesabiotech.com (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|CARM - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiyaning daromadga nisbati boltbio.com (BOLT)|Narxning daromadga nisbati HCW Biologics Inc (HCWB)|P/S multiplikatori Aptevo Therapeutics, Inc. (APVO)|Narxning daromadga nisbati aimimmuno.com AIM|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio Corporation - P/S multiplikatori|XORTX Corp (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (Vyome Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori
